About Us
The Bioengineering Research Group conducts interdisciplinary research in the fields of life sciences and nanotechnology. Our expertise includes biochemistry, chemical biology, genetic engineering, immunology, and selected areas of microbiology.
We offer a wide range of services, including testing the biological activity of various substances, producing monoclonal antibodies, biofunctionalization of nanomaterials, designing diagnostic tests, cell culture, and more. Our laboratories are equipped for analyzing interactions between proteins, proteins and DNA, ligands, and peptides. We use specialized instrumentation to measure biological activity and kinetic parameters in a wide range—from pM to mM.
We also run a cell culture laboratory, which focuses on establishing cell lines, selecting them, and optimizing technologies used in cell culture. The lab meets the highest standards required for culturing animal cells and microorganisms under controlled conditions, as well as for producing biopharmaceuticals using recombinant DNA technology. To meet the challenges posed by modern biopharmaceutical production technologies, we integrate research in cell and tissue biology with innovative microorganism cultures. We also employ the latest advances in molecular biology, “omics” technologies, and synthetic biology.
Group members
Tomasz Lipiński, PhD
Dr. Lipiński studied biotechnology at the University of Wrocław. After graduation, he joined the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences, where he obtained his doctoral degree. He completed research fellowships at the National Institute for Biological Standards and Control in Potters Bar, UK (funded by NATO), and at the University of Alberta in Edmonton, Canada, where he later worked as a Research Associate (2006–2010).
Upon returning to Poland, Dr. Lipiński joined the Wrocław Research Centre EIT+, where he worked on the interdisciplinary NAOMIS – BioSens project. His expertise includes immunochemistry, biochemistry, immunology, and microbiology. During his time at the University of Alberta, he worked on an innovative glycoconjugate vaccine against Candida albicans, designed for targeted action on dendritic cells and featuring self-adjuvanting properties.
His team conducts research through interdisciplinary projects at the intersection of life sciences and nanotechnology. The biological research focuses on analyzing the activity of natural compounds, signal transduction pathways, and designing functional conjugates. The nanotechnology research covers biofunctionalization of nanoparticles and surfaces for applications as drug or vaccine carriers, the development of innovative nanophosphors for bioimaging, and more.
Karolina Wójtowicz-Banyś, PhD
Dr. Wójtowicz-Banyś is a biotechnologist specializing in cell biology. She received her doctoral degree in biological sciences from the University of Wrocław, where she conducted research within the interdisciplinary BioTechNan project on the anticancer activity of biosurfactants. Her work focused primarily on live-cell analysis of cell membranes using advanced research methods. She also participated in other projects dedicated to innovative solutions in oncology and the cosmetics industry.
She completed her postdoctoral fellowship at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences (PAN), analyzing the molecular basis of drug resistance in colorectal cancer. She also gained experience at renowned international institutions—including the Centre d’Immunologie de Marseille-Luminy (Marseille, France) and the Technical University of Munich (Germany)—working on highly interdisciplinary projects.
